blood transfusion in cardiac surgery n.
Skip this Video
Loading SlideShow in 5 Seconds..
Blood Transfusion in Cardiac Surgery PowerPoint Presentation
Download Presentation
Blood Transfusion in Cardiac Surgery

Blood Transfusion in Cardiac Surgery

633 Vues Download Presentation
Télécharger la présentation

Blood Transfusion in Cardiac Surgery

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Blood Transfusion in Cardiac Surgery 51 yrs old female patient In ICU, POD 2 after MVrepair isoproterenol/dopamine for junctional rhythm BP 105/60, HR 75/min, CVP 5 ABG: normal. NC 4l O2 Mobilized HCT 25.5% → I unit of RBC → Hct 29%

  2. What is the problem? Blood transfusions are….. Inherently dangerous • Each transfusion poses new set of immune challenges: increase in serious complications, ICU and hospital length of stay, as well as short term and long term mortality rates. • Transfusions are not risk free and cause some degree of harm in every patient. • Serious morbidity and mortality increase with the amount transfused. • By some estimates each unit of allogeneic blood increases nosocomial infection rates by 50%. References: Hebert PC, Wells G, Blajchman MA et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17. Corwin HL. Anemia and red blood cell transfusion in the critically ill. Semin Dial 2006;19:513-6. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37:3124-57.

  3. Risks of Blood Transfusion • Fatal hemolytic reaction (1:500,000) • HIV (1:7,800,000), HCV (1:1,935,000), HBV (1:220,000) • Other infections (CMV, Yersinia, malaria, West Nile) • Human herpesvirus-8 (NEJM 2006; 355:1331) • Immunomodulation (anti-leucocyte antibodies) → TRALI (priming: recent surgery, active infection) Perioperative infection • Cancer • Problem of “old blood”: decreased deformability, 2,3- DPG, pH and NO.

  4. Transfusion and Perioperative Infection • Hill, J Trauma 2003; 54:908 • Meta-analysis of 20 perioperative studies • Increased odds ratio (OR = 3.45) for postoperative bacterial infection

  5. Transfusion and Cardiac Surgery Gerber, Crit Care Med 2008; 36:1068

  6. Blood Transfusion in the ICU Hébert, N Engl J Med 1999; 340:409 838 ICU patients with Hgb < 9 within 72 hours of admission Randomized to transfusion Hgb trigger of 7 or 10 (restrictive vs. liberal)

  7. Trial Results (I) All results favored the restrictive (Hgb 7) strategy

  8. Trial Results (II) • Subgroup analyses • Decreased 30 day mortality in less severely ill patients (9% vs. 16%) • Decreased 30 day mortality in patients < 55 years (6% vs. 13%) • Equal mortality in patients with cardiac disease (21% vs. 23%)

  9. Risks and Benefits of Transfusion • Marik, Crit Care Med 2008; 36:2667 • Systematic review of 45 observational trials • 1 study demonstrated benefit > risk • 2 studies demonstrated benefits = risks • 42 studies with risks > benefits • Pooled OR for death 1.7 (1.4 – 1.9) • Pooled OR for infection 1.8 (1.5 – 2.2) • Pooled OR for ARDS 2.5 (1.6 – 3.3)

  10. Blood usage Comparison(For all Blood products transfused) Source: UHC 2009 Blood Management Special Project Compared to its peers, SHC utilizes more than twice the units of blood per discharge.

  11. isoCABG PostOp RBC Usage Total Pts 2006 n=126 2007 n=90 2008 n=91 2009 n=102 * ^ * 1 pt w 35 units – mean 2.6 w/o outlier ^ 1 pt w 50 units – mean 3.4 w/o outlier

  12. AVR only PostOp RBC Usage Total Pts 2006 n = 30 2007 n = 47 2008 n = 68 2009 n=101

  13. Comparison of SHC 4+ RBC Unit Use with STS Like Group Iso AVR Iso CABG

  14. Stanford Blood Transfusion Management Guidelines Proposal MULTI MODALITY APPROACH BA Reitz PJA van der Starre

  15. Stanford Blood Transfusion Management Guidelines Proposal Bleeding Risk Assessed Preoperatively • Age and weight • Hct and Platelet count • Anti-platelet therapies • Stop clopidogrel 5 days pre op • Continue ASA for low risk, stop 2 days for high

  16. Stanford Blood Transfusion Management Guidelines Intra-Operative Management • Cell saver and Cell salvage • Anti-fibrinolytic drugs for high risk • DDAVP for high risk only • Retrograde priming • Autologous hemodilution • R-FVIIa for recalcitrant bleeding only • Topical hemostatics

  17. Blood Transfusion Algorithms Proposal Ferraris VA, et al. STS Guidelines on blood conservation. Ann Thorac Surg, 2007.

  18. Stanford Blood Transfusion Management Guidelines Proposal Minimize blood draws Erythropoietin Iron and nutrition Non Heme blood products used only as indicated for bleeding, with point of care testing (TEG!)

  19. Endorsement • Clinical practice guidelines for the transfusion of red blood cells and platelets endorsed throughout Medical Staff leadership • Medical Executive Committee • Department Chairs, Kevin Tabb, Bryan Bohman • Blood Transfusion Taskforce • Norm Rizk, Dan Arber, Tim Goodnough, Clarence Braddock, Magali Fontain, Lisa Shieh, Maurene Viele, Paul Maggio, Ron Pearl, Pieter van der Starre • Clinical Effectiveness Leadership Team • John Norton, Neil Olcott, Ann Weinacker, Joe Hopkins, Pravene Nath

  20. Evidence-based Guidelines • RBC Guidelines (for Hemo-dynamically stable, non-bleeding pts): • Transfusions indicated only for pts with Hgb <7g/dl (for post-cardiac surgery pts and pts with acute coronary syndrome Hgb <8 g/dl ). • Platelet Guidelines • A single dose of platelets (adult: one apheresis  product) is generally recommended as it increases the platelet count by 30,000- 60,000/ µL. (Guidelines for transfusions are based on specific disease states with corresponding platelet count triggers)

  21. EPIC Interventions:Tools to help adherence to guidelines • Platelet Order template in EPIC (Live in Sep 2010) • Embedded into the Blood product Order screen: • Decision support built in to check the previous Platelet level prior to ordering additional units. • Guidelines on disease states/platelet levels that trigger the requirement of platelet transfusion. • Indications for platelet transfusion needs to be identified when ordering • Best Practice Alert (BPA) for RBC Transfusions • Pulls in most recent hemoglobin values and scans diagnoses on the problem list for active bleeding • If the requested transfusion does NOT meet the guidelines, a “pop up” reminder flashes

  22. EPIC Best Practice Alert (BPA) : Live July 2010

  23. Platelet Guidelines A Single Dose of platelets (adult: one apheresis product) generally recommended as it increases the platelet count by 30,000- 60,000/ µl • Single unit of platelets indicated Platelet count ≤ 10,000/ µL Platelet count ≤ 20,000/ µL and signs of hemorrhagic diathesis Platelet count ≤ 50,000/ µL in a patient with active hemorrhage Platelet count ≤ 50,000/ µL in a patient with invasive procedure (recent, in-progress, planned)   Platelet count ≤ 100,000/ µL in a patient with bleeding in a closed anatomical space  (eg. CNS)   Platelet dysfunction with active or anticipated hemorrhage (TEG?)

  24. Platelets in Epic

  25. Where do we stand now? Despite the development of RBC guidelines and the Epic BPA, the vast majority of RBC transfusions (60%) continue to occur at a Hgb of 8 or above Increased guideline adherence will • Decrease clinical complications resulting from transfusion • Preserve a precious resource • Reduce overall blood utilization

  26. What you need to do!! Follow the RBC and Platelet guidelines developed by the Blood Task Committee and endorsed by the Medical Staff leadership • BPA will remind you • For actively bleeding patients, document appropriate diagnosis in the in the problem list. Transfuse a single unit of platelets • Indicate the rationale for ordering platelets while placing the order. Communicate this expectation to your peers and to your house staff Incorporate the blood guidelines, and the clinical reasoning behind them, into the teaching and communication provided to interns and residents Direct feedback or questions to Blood Task Force regarding adoption of guidelines